Facing Dementia During the COVID-19 Outbreak
- PMID: 32516441
- PMCID: PMC7300919
- DOI: 10.1111/jgs.16644
Facing Dementia During the COVID-19 Outbreak
Conflict of interest statement
Authors have no competing interest to disclose for the present study.
Marco Canevelli is supported by a research grant of the Italian Ministry of Health (GR‐2016‐02364975) for the project “Dementia in Immigrants and Ethnic Minorities Living in Italy: Clinical‐Epidemiological Aspects and Public Health Perspectives” (ImmiDem). Matteo Cesari has received honoraria for presentations at scientific meetings and/or research funding from Nestlé and Pfizer. He is involved in the coordination of an Innovative Medicines Initiative–funded project (including partners from the European Federation Pharmaceutical Industries and Associates [Sanofi, Novartis, Servier, GSK, and Lilly]).
Figures
Comment in
-
Letter to the Editor: COVID-19 and the Impact on Caregivers.J Frailty Aging. 2022;11(3):335-336. doi: 10.14283/jfa.2022.41. J Frailty Aging. 2022. PMID: 35799442 Free PMC article. No abstract available.
References
-
- SARS‐CoV‐2 Surveillance Group . Istituto Superiore di Sanità. Characteristics of SARS‐CoV‐2 patients dying in Italy. April 29, 2020. 2020. https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019.... Accessed May 6, 2020.
-
- Alzheimer Europe . COVID‐19 ‐ living with dementia. https://www.alzheimer-europe.org/Living-with-dementia/COVID-19. Accessed May 7, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical